NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES
|
|
- Annabella Moore
- 7 years ago
- Views:
Transcription
1 NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or ovarian cancer should be directed to Breast Care Nurse Specialist, Nicky Scott (NS). All women within the City Hospital catchment area currently referred directly to clinical genetics will also follow this pathway. All referrals will be sent a Family History Questionnaire. Women Identified at other Nottingham Breast or Ovarian Clinic All women should be given a Family History Questionnaire to complete and referred to NS before being given an appointment for the Family History Clinic. If a questionnaire is not available NS will arrange for one to be sent. No woman should be given a direct appointment at the Family History Clinic. Family History Questionnaires These will be returned to N.S for assessment. Women failing to return a questionnaire within 3 months will be sent one reminder letter (copy to GP) with a further copy of the questionnaire. A copy of the questionnaire will be filed in the case notes. GUIDELINES FOR THE RISK STRATIFICATION OF FAMILIES WITH BREAST/OVARIAN CANCER The family history can be defined as being low, moderate or high risk. Low Risk Moderate Risk High - Less than 2 x population lifetime risk of breast cancer x population lifetime risk of breast cancer - Greater that 3 x population lifetime risk of breast cancer NB: Women with Jewish Ancestry are around 5-10 times more likely to carry BRCA 1 or BRCA 2 mutations than women in the non-jewish population.
2 WOMEN AT LOW RISK OF BREAST CANCER These women are not currently offered regular screening. They will be sent a letter reassuring them that their family history is very unlikely to be significant. All minimal risk women aged under 50 will be entered into the Family History Clinic database. Patients with the following family histories, on the same side of the family, fall into the moderate and high risk group. Patients with the following family histories, on the same side of the family, fall into the moderate and high risk groups: MODERATE RISK 3 Relatives Three 1 st or 2 nd degree relatives with breast cancer at an average age of over 60* One relative with ovarian cancer and two 1 st or 2 nd degree relatives with breast cancer where the average age for the breast cancer is over 60*. 2 Relatives One 1 st degree relative and one 1 st or 2 nd degree relative with an average age of breast cancer over 50 and under 60*. One ovarian cancer and one 1 st or 2 nd degree relative with breast cancer over 50*. One 1 st or 2 nd degree relative with bilateral breast cancer and one 1 st or 2 nd degree relative with breast cancer over 60*. 1 Relative A 1 st degree relative with breast cancer under 40. A 1 st degree relative with male breast cancer at any age. A 1 st degree relative with bilateral breast cancer, where the average age of diagnosis is over 50. First degree relatives include parents, siblings and children. Second degree relatives include grandparents, aunts and uncles, nephews and nieces. *One should be a first degree relative unless the family history is on the paternal side of the family.
3 MAMMOGRAPHIC SCREENING Start annual screening age 40. Transfer to NHSBSP age 50yrs HIGH RISK 4 or more Relatives Four or more close relatives with breast and / or ovarian cancer *. 3 Relatives Three 1 st or 2 nd degree relatives with an average age of breast cancer under 60*. One relative with ovarian cancer and two 1 st or 2 nd degree relatives with breast cancer where the average age for the breast cancer is under 60*. One male breast cancer at any age and 2 female breast cancers with an average age under 60 2 Relatives One 1 st and one 1 st or 2 nd degree relatives with an average age of breast cancer under 50. One 1 st and one 1 st or 2 nd degree relative with ovarian cancer. One ovarian cancer and one 1 st or 2 nd degree relative with breast cancer under 50*. One 1 st or 2 nd degree relative with bilateral breast cancer and one 1 st or 2 nd degree relative with breast cancer under 60* or ovarian cancer at any age One male breast cancer at any age and a female breast cancer under 50 or an ovarian cancer at any age 1 Relative A 1 st degree relative with both breast cancer under 50 and ovarian cancer. A 1 st degree relative with bilateral breast cancer, both under 50. First degree relatives include parents, siblings and children. Second degree relatives include grandparents, aunts and uncles, nephews and nieces. *One should be a first degree relative unless the family history is on the paternal side of the family.
4 Assumptions - 2nd degree paternal confers same risk as 1 st maternal degree Other High Risk Groups Mantle Radiotherapy Known genetic syndrome (BRCA mutation carriers, Cowden s, Blooms, Peutz-Jeghers, Li Fraumeni MAMMOGRAPHIC SCREENING Start annual screening at age 35. Transfer to NHSBSP age 60yrs At first presentation these women will also attend the New Referral Family History Clinic. They will receive information on screening and if appropriate genetic testing. They will undergo screening mammography as per guidelines. These women will be invited to attend for annual screening by mammography. The women will be informed of their mammogram result by post. All abnormal mammogram results will be recalled by letter and the appropriate action taken as advised by Consultant Radiologist. Where appropriate high-risk women will be offered counselling by the Clinical Genetic Service. All women in this risk group will be entered into the Nottingham Family History Database. Women BRCA 1 & 2 positive or 50% risk by age 40 to start mammography at age 30. (Density of initial mammogram to be reviewed by Consultant Radiologist. Annual MRI will also be carried out until the age of 50yrs. Patients who have had mantle radiotherapy will also receive annual MRI until the age of 50yrs. Mutation Carriers under the age of 30yrs to see NS annually as a follow up on BFH2F.
5
6 Ovarian Cancer Screening All referrals of asymptomatic women with a family history of ovarian cancer will be sent to NS. All symptomatic referrals will be sent to Consultant Gynaecologist. Asymptomatic women will be sent a questionnaire, which will be returned to NS for review. All families with a significant history of breast cancer will pass through the normal pathway as outlined above Prophylactic oophorectomy is also an option for women with a family history of ovarian cancer. This is recommended for BRCA mutation carriers. In those who cannot undergo genetic testing or for whom testing is uninformative prophylactic oophorectomy my be considered. However, such women should be referred to Clinical Genetics for a full discussion of potential risks and benefits. There is no evidence to suggest that the prophylactic oophorectomy should be sold to non-mutation carriers as a good option. Consultant Gynaecologist will see all women who have abnormal ultrasound scans or CA 125 measurements or who become symptomatic. (Ultrasounds and CA125 will not be performed routinely). There are various patient information leaflets and documentation to support this Guideline and these can be obtained from Nicky Scott Nurse Specialist Family History Ext
7
8 SYMPTOMATIC GENETIC TESTING Patients with breast cancer who fulfil the above criteria for genetic testing can be offered testing without referral to Clinical Genetics. Such patients should be seen by Nicky Scott or Jackie O Sullivan initially. ASYMPTOMATIC GENETIC TESTING Patients without breast cancer who fulfil the about criteria for genetic testing can be offered testing and referred to Clinical Genetics. WOMEN CONSIDERING RISK REDUCING SURGERY All women with BRCA mutations, or those at 50% risk of carrying a mutation should be offered the opportunity to attend the Tea Party. Blood Storage Women at family history risk and high risk will be offered storage of blood from an affected relative to facilitate genetic testing should it be indicated in the future. Consent will be obtained and DNA will be stored in the Department of Molecular Genetics. Women, who test negative, where a mutation has been identified in an affected relative, will be sent a standard letter by Clinical Genetics disclosing the result and discharged from the Family History Clinic. Women who have been diagnosed with breast cancer who test positive will be informed by Nicky Scott or Jackie O Sullivan and be offered referral to the Clinical Genetic Service. They will then be referred to the appropriate Consultant Surgeon and counselled regarding risk management. They will be sent an information leaflet prior to attending for this appointment. ATYPICAL DUCTAL HYPERPLASIA (ADH) ATYPICAL LOBULAR HYPERPLASIA (ALH) LOBULAR CARCINOMA IN-SITU (LCIS) Any patient with the above diagnosis under the age of 50 years will be offered annual mammography until the age of 50yrs (Clinic BFH/MM) when they will be discharged to National Breast Screening Service (NHSBSP). Discharge from Family History Clinic Women with a moderate risk family history will be discharged to the National Screening Programme (NHSBSP) at age 50.
9 Women with a high risk family history will be discharged to the National Screening Programme (NHSBSP) at age 60. Hereditary Breast and/or Ovarian families waiting for genetic testing results or for whom genetic testing is uninformative/not possible. Such women will be discharged at age 60 yrs to the NHSBSP. Known BRCA1 and BRCA2 carriers will be screened until age 70 according to the National Breast Screening Guidelines. Non Attendees (DNA s) Failure to attend for appointment discharge back to GP no further appointment given. JAN.16
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 This guide has three parts: 1. Information for health professionals 2. Tables
More informationBreast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW
Breast Cancer Screening Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Learning Objectives Identify risk factors for breast cancer What to do with this information - GP
More informationBRCA1 & BRCA2 GeneHealth UK
BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 3 people developing cancer at some point in their lifetime. Breast cancer occurs
More informationBreast Cancer Screening
Breast Cancer Screening Summary of the Clinical Practice Guideline September 2013 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate
More informationThe Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine
The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationGenetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service
Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How
More informationFamilial Breast Cancer Referrals and Risk Management
Familial Breast Cancer Referrals and Risk Management Presented by: Helen Mountain Genetic Counsellor Genetic Services of WA Perth (KEMH and PMH) Joondalup Rockingham Bunbury Geraldton Kalgoorlie Albany
More informationGENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP
GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT
More informationA Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer
A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer Sally Herschorn, MD Associate Professor of Radiology University of Vermont College of Medicine Medical Director
More informationExpansion of the Ontario Breast Screening Program (OBSP) to Include Women Aged 30 to 69 at High Risk for Breast Cancer
To: Physicians, Nurse Practitioners, Genetics Clinics, Hospitals and LHINs Published By: Implementation Branch Date Issued: June 27, 2011 Bulletin #: 10016 Re: Expansion of the Ontario Breast Screening
More informationHereditary Breast and Ovarian Cancer (HBOC)
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Hereditary Breast and Ovarian Cancer (HBOC) Information for women with an increased lifetime risk of breast and ovarian cancer What
More informationif your family has a history
if your family has a history OF CANCER. put it to the test. Learn about your risk for hereditary and ovarian and how you can reduce it. do you have a family history of Breast or Ovarian Cancer? what does
More informationAre You at Risk for Ovarian Cancer?
Are You at Risk for Ovarian Cancer? A Woman s Guide Read this brochure to learn more about ovarian cancer symptoms, risk factors and what you can do to reduce your risk. ALL WOMEN HAVE SOME RISK OF OVARIAN
More informationPrevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)
הסיכוי שבסיכון PREVENTION GENERATION Prevention GENEration The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC) We thank Prof. Ephrat Levy-Lahad Director, Medical
More informationBRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet
BRCA Genes and Inherited Breast and Ovarian Cancer Patient information leaflet This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could
More informationBRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide
BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide What is Hereditary? Breast cancer is the most common cancer in women in the U.S. (it affects about 1 in 8 women). Ovarian
More informationUnderstanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service
Understanding Hereditary Breast and Ovarian Cancer Maritime Hereditary Cancer Service General Information Cancer is very common. About one in three (33%) people are diagnosed with some form of cancer during
More informationPatient Support Guide
Patient Support Guide to genetic testing for hereditary breast and ovarian cancer syndrome Testing for BRCA1 and BRCA2 is available from Quest Diagnostics. Quest Diagnostics Patient Support Guide to Genetic
More informationBreast cancer in families. This booklet explains what a family history of breast cancer is, and what this may mean for you or your family.
Breast cancer in families This booklet explains what a family history of breast cancer is, and what this may mean for you or your family. Worried Lorem about ipsum breast dolore cancer estes Contents
More informationBreastScreen and You. Information about mammographic screening
BreastScreen and You Information about mammographic screening This information is about screening for breast cancer. It aims to help you choose whether or not you take part in the BreastScreen Australia
More informationBreast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org
Breast Cancer s Link to Ovarian Cancer: It s in Your Genes foundationforwomenscancer.org There are now more than 2.6 million women in America who have been diagnosed with breast cancer. A very small fraction
More informationFollow-up care plan after treatment for breast cancer. A guide for General Practitioners
Follow-up care plan after treatment for breast cancer A guide for General Practitioners This leaflet provides information for GPs on the follow-up care required by women who had breast cancer. It is for
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for
More informationScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015
ScreenWise Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015 ScreenWise Three programs working together to bring quality screening services to Oregon residents Why we all do this work
More informationBreast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA
Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for
More informationCancer Prevention and Screening Hong Kong Perspective Professor TH LAM
Cancer Prevention and Screening Hong Kong Perspective Professor TH LAM Chairman, Cancer Expert Working Group on Prevention and Screening Chair Professor of Community Medicine, School of Public Health,
More informationGenetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2)
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationBreast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
More informationpatient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer
patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer What is hereditary cancer? Cancer affects many people in the U.S.: breast cancer affects 1 in 8 women and ovarian
More informationHow To Decide If You Should Get A Mammogram
American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women
More informationCRICO Breast Care Management Algorithm
CRICO Breast Care Management Algorithm A DECISION SUPPORT TOOL Created: 1995 Revised: 2000, 2003, 2010 Current: 2014 Warm Gray 10 PC: 20c 29m 28y 56k 7417 PC: 0c 80m 80y 0k Improving Breast Patient Safety
More informationU.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet
U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet 1. Invitation You are being invited to take part in a research study. Before you decide it is important for you
More informationParker Adventist Hospital Genetic Counseling Family History Questionnaire
PATIENT NAME: To be completed by Questionnaire received: Genetic Counseling Clinic: Parker Adventist Hospital Genetic Counseling History Questionnaire Appointment: You have been referred to Genetic Counseling
More informationBreast Screening Explained. We can supply this information in other languages, in large print, on audio or in Braille.
Breast Screening Explained We can supply this information in other languages, in large print, on audio or in Braille. Breast Screening Explained This leaflet tells you about free breast screening. Breast
More informationThe Department of Vermont Health Access Medical Policy
State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department
More informationOffice of Population Health Genomics
Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation
More informationOvarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
More informationBRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010
BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations
More informationScreening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
More informationUnderstanding Your Risk of Ovarian Cancer
Understanding Your Risk of Ovarian Cancer A WOMAN S GUIDE This brochure is made possible through partnership support from Project Hope for Ovarian Cancer Research and Education. Project HOPE FOR OVARIAN
More informationDuctal carcinoma in situ (DCIS)
DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made
More informationName of Policy: Genetic Testing for Hereditary Breast and/or Ovarian Cancer
Name of Policy: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Policy #: 513 Latest Review Date: January 2014 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule,
More informationGENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110
GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic
More informationBreast Density Legislation: Implications for primary care providers
Breast Density Legislation: Implications for primary care providers Deborah J. Rhodes MD Associate Professor of Medicine 2012 MFMER slide-1 Disclosure Relevant financial relationship(s) None Off-label
More informationThis vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years
Breast Cancer 2015 Annex C Background 1. Breast cancer is the most common cancer in women in England with (not including cases of ductal carcinoma in situ (DCIS) 1 ) 39,681 new cases diagnosed in 2008
More informationBreast cancer and genetics
Breast cancer and genetics Cancer and genes Our bodies are made up of millions of cells. Each cell contains a complete set of genes. We have thousands of genes. We each inherit two copies of most genes,
More informationMEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test
MEDICAL POLICY SUBJECT: GENETIC TESTING FOR, 10/15/15 PAGE: 1 OF: 12 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationEvaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003
Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal
More informationNicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
More informationBreast cancer in the family
Birmingham Women's NHS Foundation Trust Breast cancer in the family Information for women with a slightly increased risk of breast cancer This is a no smoking hospital Breast cancer in the family what
More informationGuideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
More informationBREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1
FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 Hello, my name is Rachel Jankowitz, I m an assistant professor of medicine in the Division of Hematology Oncology at the University of Pittsburgh
More informationCancer: Genetic testing can save lives
Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who
More informationAmerican Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography Debbie Saslow, PhD; Carla Boetes, MD, PhD; Wylie Burke, MD, PhD; Steven Harms, MD; Martin O. Leach, PhD; Constance
More informationBreast Cancer in the Family
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family
More informationBreast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
More informationIllinois Insurance Facts Illinois Department of Insurance Coverage for the Diagnosis and Treatment of Breast Conditions
Illinois Insurance Facts Illinois Department of Insurance Coverage for the Diagnosis and Treatment of Breast Conditions Revised May 2015 Note: This information was developed to provide consumers with general
More informationGenetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -
Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall
More informationCost-effectiveness of predictive genetic tests for familial breast and ovarian cancer
Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer NIKKI BREHENY, ELIZABETH GEELHOED, JACK GOLDBLATT & PETER O LEARY Abstract Aim: To examine the relative cost-effectiveness
More informationFact sheet 9. Screening for ovarian cancer
Fact sheet 9 Screening for ovarian cancer Ovacome is a national charity providing advice and support to women with ovarian cancer. We give information about symptoms, diagnosis, treatment, research and
More informationOregon Survey Instrument
Oregon Survey Instrument Cancer Genetic Insurance Questions for Insurers Q1a. Do you have written policies on your coverage of cancer genetic testing, counseling, and follow-up procedures for breast and
More informationHereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center
Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary
More informationBenefits Collaborative Policy Statement WOMEN S HEALTH SERVICES
Page 1 uf 5 The services listed below are not inclusive of all services available to women on Medicaid, but WOMEN S HEALTH SERVICES Benefits Collaborative Policy Statement Women s health services are preventative
More informationHEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk?
HEREDITARY BREAST CANCER BRCA1 Faulty gene INFORMATION LEAFLET How Do I Reduce My Risk? Page 1 CONTENTS Part A 1 What is BRCA1 2 How does BRCA1 affect a person s risk of cancer? 3Testing for BRCA1 4Benefits
More informationPersonalized Breast Screening Service
Frequently Asked Questions WHAT IS BREAST DENSITY? Breasts are made up of a mixture of fibrous, glandular and fatty tissue. Your breasts are considered if you have predominantly fibrous or glandular tissue
More informationGuideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
More informationINTERVENTIONS BREAST CANCER GENETICS YOUNG BREAST CANCER SURVIVORS
INTERVENTIONS BREAST CANCER GENETICS YOUNG BREAST CANCER SURVIVORS AND THEIR AT-RISK RELATIVES Maria C. Katapodi, PhD, RN, FAAN Professor of Nursing Faculty of Medicine, University of Basel, Switzerland
More informationMedical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011
Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: May 2015 Policy No: 02 Effective Date:
More informationBRCA1 and BRCA2 for men
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department BRCA1 and BRCA2 for men Information for men from families with a known alteration in the BRCA1/2 gene Introduction BRCA1 and BRCA2
More informationInfrared Thermography Not a Useful Breast Cancer Screening Tool
Contact: Jeanne-Marie Phillips Sharon Grutman HealthFlash Marketing The American Society of Breast Surgeons 203-977-3333 877-992-5470 Infrared Thermography Not a Useful Breast Cancer Screening Tool Mammography
More informationHereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013
Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your
More informationA Beginner s Guide to BRCA1 and BRCA2
i A Beginner s Guide to BRCA1 and BRCA2 A Beginner s Guide to BRCA1 and BRCA2 Contents Page Introduction What does it mean to have a BRCA gene mutation? 1 Background information about the BRCA1/2 genes
More informationCancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer
Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer Information for women and their families 1 What is breast cancer? The female breast is mainly consisted
More informationCONSOLIDATED GUIDANCE ON STANDARDS FOR THE NHS BREAST SCREENING PROGRAMME
CONSOLIDATED GUIDANCE ON STANDARDS FOR THE NHS BREAST SCREENING PROGRAMME NHSBSP Publication No 60 (Version 2) April 2005 Published by: NHS Cancer Screening Programmes The Manor House 260 Ecclesall Road
More informationBreast Cancer Screening Clinical Practice Guideline
NATIONAL CLINICAL PRACTICE GUIDELINE Breast Cancer Screening Clinical Practice Guideline This guideline is informational only. It is not intended or designed as a substitute for the reasonable exercise
More informationBreast Cancer Screening 101:
Breast Cancer Screening 101: Screening Guidelines and Imaging Modalities Robert Smith, PhD American Cancer Society Cheryl Herman, MD NAPBC Education Committee November 23, 2015 Webinar Topics - Burden
More informationVI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS
ACR BI-RADS ATLAS VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS American College of Radiology 55 ACR BI-RADS ATLAS A. All Breast Imaging Modalities 1. According to the BI-RADS Atlas,
More informationInsurance Protections and Coverage
Insurance Protections and Coverage The First Line of Defense: Application of Breast Cancer Genomics Standards in Primary Care Friday, February 21, 2014 Presenter: Lisa K. Liang, Esq. Health Law Unit (Breast
More informationNHS breast screening Helping you decide
NHS breast screening Helping you decide What is breast cancer? 2 What is breast screening? 3 Breast screening results 6 Making a choice the possible benefits 9 and risks of breast screening What are the
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationThe Greater Atlanta Affiliate 2004-2005 Grant Recipients
The Greater Atlanta Affiliate 2004-2005 Grant Recipients Atlanta Lesbian Cancer Initiative Treatment, Education, Support & Screening: This award supports psychosocial, informational, and physical support
More informationA survey conducted by Ovarian Cancer Australia: A report summarising findings on a family history and genetic testing survey
1 P a g e A survey conducted by Ovarian Cancer Australia: A report summarising findings on a family history and genetic testing survey Executive Summary Introduction Ovarian Cancer Australia (OCA) surveyed
More informationHereditary Breast Cancer Testing. Diagnostic
Hereditary Cancer Testing Diagnostic New solutions for hereditary breast cancer. Identifying and understanding the genetic contribution to breast cancer allows for individualized disease management and
More informationCommon Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
More informationYour Jewish Genes. Hereditary Breast Cancer and Ovarian Cancer
E D U C A T I O N A L B O O K L E T S E R I E S Your Jewish Genes Hereditary Breast Cancer and Ovarian Cancer 2011 Sharsheret, Inc. All rights reserved. 07/11 3000 Your Jewish Genes Hereditary Breast Cancer
More informationCancer Genetic Counseling
Cancer Genetic Counseling Guest Expert: Ellen, MS Director of the Yale Cancer Center Cancer Genetic Counseling Program www.wnpr.org www.yalecancercenter.org I am Bruce Barber and this is Yale Cancer Center
More informationScreening for ovarian cancer Page 1 of 5 Ovacome
Fact sheet 9 Screening for ovarian cancer Ovacome is a national charity providing advice and support to women with ovarian cancer. We give information about symptoms, diagnosis, treatment, research and
More informationBRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS
BRCA1 and BRCA2 BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 Breast cancer is the most common cancer in women, diagnosed in
More informationReduce Your Risk of Breast Cancer
Reduce Your Risk of Breast Cancer Reduce Your Risk of Breast Cancer There was no history in my family. But the test was positive and it was breast cancer. I was so shocked, I couldn t believe it. ~ Colette
More informationImpact of Breast Cancer Genetic Testing on Insurance Issues
Impact of Breast Cancer Genetic Testing on Insurance Issues Prepared by the Health Research Unit September 1999 Introduction The discoveries of BRCA1 and BRCA2, two cancer-susceptibility genes, raise serious
More informationHow To Be A Breast Consultant Radiographer
Overview Role of a Consultant Radiographer A reflective account Judith Kelly Peter Hogg Part 1 Clinical roles of the breast consultant radiographer Part 2 A reflection on aspects of the broader consultant
More informationPhyllodes tumours: borderline malignant and malignant
Phyllodes tumours: borderline malignant and malignant This booklet is for people who would like more information on borderline malignant or malignant phyllodes tumours. It describes what they are, the
More informationSummary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals
Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals Talk with patients about ü Potential benefits, harms, and unknowns of cancer ü
More informationGuide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
More informationRisk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth
Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes Dr. med. Henrik Csaba Horváth Why is risk stratification for colorectal cancer (CRC)
More informationHereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel
P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t
More informationInvasive lobular breast cancer
Invasive lobular breast cancer This booklet is about invasive lobular breast cancer. It describes what invasive lobular breast cancer is, the symptoms, how it s diagnosed and possible treatments. Diagnosed
More informationProgress and Prospects in Ovarian Cancer Screening and Prevention
Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian
More information